Every one of those 1 sits in a single category, pharma. Of the tracked stories, 1 of 1 also mention Dadachanji Group, the most common co-covered peer. Each carries 4 original sources on average. We currently track 1 Biotech story that mention Tubular glass packaging, all published on September 4, 2026.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Tubular glass packaging
Every one of those 1 sits in a single category, pharma. Of the tracked stories, 1 of 1 also mention Dadachanji Group, the most common co-covered peer. Each carries 4 original sources on average. We currently track 1 Biotech story that mention Tubular glass packaging, all published on September 4, 2026.
Stories tracked
1
Sources per story
4
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 3 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Tubular glass packaging. Shared-story counts are live from our verified record — not editorial picks.
Dadachanji Group announces the launch of KAISHA Pharma with an initial 45 million investment and a manufacturing footprint of more than 300,000 square feet.
KAISHA Pharma enters the injectables packaging market with a 45M initial investment and more than 300,000 sq ft of manufacturing capacity, targeting biologics and advanced therapeutics with specialty glass containment and ready-to-use formats.
Tubular glass packaging is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.